#153648

Anti-Inhibin a [PO23/32]

Cat. #153648

Anti-Inhibin a [PO23/32]

Cat. #: 153648

Sub-type: Primary antibody

Unit size: 100 ug

Availability: 10-12 weeks

Target: Inhibin a

Class: Monoclonal

Application: ELISA

Reactivity: Human

Host: Mouse

£300.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Institute: BioServ UK Ltd

Tool Details
Target Details
Applications
Handling
References

Tool Details

*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)

  • Name: Anti-Inhibin a [PO23/32]
  • Alternate name: Inhibin alpha chain, INHA
  • Research fields: Cancer;Cell signaling and signal transduction
  • Clone: PO 23/32
  • Tool sub type: Primary antibody
  • Class: Monoclonal
  • Conjugation: Unconjugated
  • Molecular weight: 40 kDa
  • Strain: Balb/c
  • Reactivity: Human
  • Host: Mouse
  • Application: ELISA
  • Description: Higher levels of inhibin Î? have been associated with a higher risk of cancer progression and recurrence. Clone PO 23/32 is useful in detecting inhibin Î? levels in cancer cells.
  • Immunogen: Synthetic peptide corresponding to epitope region aa109-123 of the aC region of a subunit of inhibin A
  • Isotype: IgG2a
  • Myeloma used: Sp2/0-Ag14
  • Recommended controls: Testis or Ovary

Target Details

  • Target: Inhibin a
  • Molecular weight: 40 kDa
  • Tissue cell line specificity: Testis or Ovary
  • Target background: Higher levels of inhibin a have been associated with a higher risk of cancer progression and recurrence. Clone PO 23/32 is useful in detecting inhibin a levels in cancer cells.

Applications

  • Application: ELISA

Handling

  • Format: Liquid
  • Unit size: 100 ug
  • Shipping conditions: Shipping at 4° C

References

  • Robertson et al. 2002. J Clin Endocrinol Metab. 87(2):816-24. PMID: 11836327.
  • Characterization of inhibin forms and their measurement by an inhibin alpha-subunit ELISA in serum from postmenopausal women with ovarian cancer.
  • Robertson et al. 2001. Mol Cell Endocrinol. 180(1-2):79-86. PMID: 11451575.
  • Development of an inhibin alpha subunit ELISA with broad specificity.